2. As of noon trading, Catamaran ( CTRX) is down $0.69 (-1.7%) to $40.55 on light volume. Thus far, 687,207 shares of Catamaran exchanged hands as compared to its average daily volume of 2.9 million shares. The stock has ranged in price between $40.38-$41.41 after having opened the day at $41.41 as compared to the previous trading day's close of $41.24.

Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America. The company operates in two segments: PBM and HCIT. Catamaran has a market cap of $8.7 billion and is part of the health care sector. Shares are down 13.1% year-to-date as of the close of trading on Tuesday. Currently there are 13 analysts that rate Catamaran a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Catamaran as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Catamaran Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

No Buyers for All of Tenet, Analysts Say

Hurricane Irma Now Category 4, Still Headed for Florida

Community Health Stock Surges as Investor Seeks New CEO

These Stocks Are Ready to Reverse Course

Why More Limbo on Healthcare Reform Is Bad News for Hospital Stocks